Endothelin in myocardial infarction  by Kolettis, Theofilos M.
Session 10: Cardiology, Hypertension, Vascular Disease
Endothelin in myocardial infarction
Theoﬁlos M. Kolettis
University of Ioannina, Greece
E-mail address: thkolet@uoi.gr
The effects of ET-1 on myocardial necrosis: Myocardial infarction
increases plasma ET-1 levels shortly after acute coronary occlusion,
causing release from intracellular-storages and de novo production. The
effects of ET-1 on the ischaemic and necrotic areas in the absence of
reperfusion are debated, but ET-1mayplay a role in reperfusion injury. In
in vivo rat-models of ischaemia-reperfusion, ETA- or dual-(ETA and ETB)
receptor blockade have been shown to decreasemyocardial necrosis and
improve left ventricular haemodynamics. Importantly, favourable results
were demonstrated in a recent small-scale clinical study, in which short-
term, selective ETA-receptor blockade prior to percutaneous coronary
intervention improved myocardial perfusion, decreased infarct size and
improved left ventricular function. ET-1 and sympathetic stimulation:
During acute myocardial infarction, ET-1 increases catecholamine-
release from the adrenal glands and modulates norepinephrine-release
in sympathetic nerve-endings in the ventricular myocardium. These
effects result in local norepinephrine-release via ETA-receptor activation,
whereas the ETB-receptor appears to exert a protective role by
decreasing early sympathetic drive. Arrhythmogenesis: ET-1 exerts
signiﬁcant electrophysiologic effects and contributes to ventricular
arrhythmogenesis. ET-1 induces spontaneous calcium-transients, lead-
ing into early afterdepolarizations, and inhibits the delayed-rectiﬁer
potassium-current. In the in vivo rat-model of myocardial infarction
without reperfusion, lower incidence of ventricular tachyarrhythmias
and shorter episode duration were reported after selective ETA-receptor
blockade, resulting in lower arrhythmic-mortality. In the same animal
model, dual (ETA and ETB) receptor blockade decreased arrhythmo-
genesis, but this effect was evident only during the later-phase of acute
infarction. These results point towards an arrhythmogenic effect of ET-1
during acute infarction, mediatedmainly by the ETA receptor, consisting
of increased sympathetic activation and enhanced repolarization in-
homogeneity. The restoration of blood-ﬂow after a prolonged ischaemic
period causes marked electrophysiological changes and causes a second
wave of myocardial necrosis, associated with arrhythmogenesis. Given
the possible role of ET-1 in reperfusion injury, the antiarrhythmic
potential of ET-receptor blockade during ischaemia-reperfusion has
been subject of research for over a decade. However, hitherto studies
have produced conﬂicting results, possibly due to differences in
experimental-protocols, including ex vivo and in vivo models, and the
time-window for arrhythmia-recording. Moreover, exogenously admin-
istered ET-1 during ischaemia-reperfusion in some studies may even
exert antiarrhythmic effects, possibly via a preconditioning effect.
Conclusions: The effects of ET-1 during myocardial ischaemia and
infarction constitute an intriguing topic with potential clinical ramiﬁca-
tions. Further research is required on the arrhythmogenic effects of ET-1
during acute myocardial infarction, placing emphasis on those observed
during the pre-hospital phase. Since ventricular tachycardia and
ventricular ﬁbrillation shortly after acute coronary occlusion account
for the vast majority of sudden cardiac death cases, prompt understand-
ing of the underlying pathophysiology may lead to effective preventive
therapeutic strategies.
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Background. Despite the accumulating genetic and molecular
understandings into hypertrophic cardiomyopathy (HCM), it remains
unclear how this condition develops and worsens pathologically and
clinically in terms of the genetic-environmental interactions. Thus,
establishing human disease models for HCM would help us to evaluate
the disease mechanisms and novel therapeutic strategies. Emerging
patient-speciﬁc induced pluripotent stem cell (iPSC) techniques hold
much promise for these tasks. Hypothesis. Interactions between genetic
backgrounds and environmental factors are involved in the progression
of HCM.Methods. To clarify candidate disease-promoting environmental
factors, iPSCs fromunrelated three patientswithHCMand three healthy-
control subjectswere generated. The cardiomyocytes differentiated from
each iPSC line were stimulated by several cardiomyocyte hypertrophy-
promoting factors. The HCM pathological phenotypes were examined
based on themorphological properties, such as cell size and intracellular
myoﬁlament structures, in randomly chosen cardiac troponin-T-positive
singled cardiomyocytes. Next, a high-speed video imaging with motion
vector prediction algorithm revealed physiological contractile dynamics
in the iPSC-derived singled cardiomyocytes. Results. Control- and HCM-
iPSC-derived cardiomyocytes were similar under the basal condition in
pathological features and contractile dynamics. However, only the HCM-
iPSC-derived cardiomyocytes showed pathological phenotypes, such as
cardiomyocyte hypertrophy and facilitated intracellular myoﬁlament
disorganization in the presence of endothelin-1 (ET-1) administration
with a dose-dependent manner. Moreover, physiological analyses
revealed ET-1-induced contractile dispersion in the self-beating HCM-
iPSC-derived cardiomyocytes. Finally, these deleterious effects were
rescued by blocking the endothelin receptor type-A. Conclusions.
Interactions between genetic backgrounds and the environmental factor,
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